Each week we highlight five things affecting the life sciences industry. Here's the latest. FTC appointments possibly signal decreased scrutiny on biopharma M&A President-elect Donald Trump's nomination of Andrew Ferguson and Mark Meador to the Federal Trade Commission signals a potential shift ... READ MORE >
biopharma
5 things to know in life sciences: Week of December 2, 2024
Each week we highlight five things affecting the life sciences industry. Here's the latest. How the Trump administration could affect the life sciences industry The incoming Trump administration may promote increased mergers and acquisitions activity in the biopharma sector due to a less restrictive ... READ MORE >
5 things to know in life sciences: Week of November 18, 2024
Each week we highlight five things affecting the life sciences industry. Here's the latest. CAR-T therapy for lupus gains attention CAR-T cell therapy shows significant potential in treating lupus—as discussed at ACR 2024--with early trials indicating improved patient outcomes and reduced disease ... READ MORE >
5 things to know in life sciences: Week of November 11, 2024
Each week we highlight five things affecting the life sciences industry. Here's the latest. Addressing clinical trials challenges in biopharma ecosystem Experts at the Outsourcing in Clinical Trials Conference in New England discussed strategies for navigating the challenging biopharma ecosystem, ... READ MORE >
5 things to know in life sciences: Week of November 4, 2024
Each week we highlight five things affecting the life sciences industry. Here's the latest. How the election might affect the life sciences industry Fierce Pharma provides some initial thoughts regarding the impact of Donald Trump’s election. Issues considered include changes to the Inflation ... READ MORE >
5 things to know in life sciences: Week of October 28, 2024
Each week we highlight five things affecting the life sciences industry. Here's the latest. UK Parliament considering new post-market surveillance regulations The UK government has introduced new regulations for post-market surveillance of medical devices, aiming to enhance patient safety and device ... READ MORE >
5 things to know in life sciences: Week of October 21, 2024
Each week we highlight five things affecting the life sciences industry. Here's the latest. New antibody discovery software unveiled Dotmatics, a research and development software provider, is launching a platform for therapeutic antibody discovery that integrates sequence visualization, antibody ... READ MORE >
5 things to know in life sciences: Week of October 14, 2024
Each week we highlight five things affecting the life sciences industry. Here's the latest. German company announces positive results for a celiac disease trial Topas Therapeutics, a German biotech company, reported positive phase 2a results for its celiac disease candidate, showing a good safety ... READ MORE >
5 things to know in life sciences: Week of October 7, 2024
Each week we highlight five things affecting the life sciences industry. Here's the latest. FDA approves at-home COVID/flu combo test for fall season The U.S. Food and Drug Administration has approved an at-home test by Healgen that detects both COVID-19 and influenza A and B, marking a significant ... READ MORE >
5 things to know in life sciences: Week of September 30, 2024
Each week we highlight five things affecting the life sciences industry. Here's the latest. Positive outlook for CDMOs heading into 2025 Despite challenges in the biopharma contracting sector following the COVID-19 boom, 49% of contract development and manufacturing organizations remain ... READ MORE >